Weight Loss Drugs Are Not the Magic Pill

Weight loss and healthier lifestyles again take center stage for most people’s 2024 New Year resolutions. According to a recent <a href="https://www.forbes.com/health/mind/new-years-resolutions-%20statistics/#:~:text=Most%20Common%20New%20Year&#39;s%20Resolutions,-%20For%202024%2C%20the&amp;text=fitness%20(48%25)-%20,Improved%20finances%20(38%25),Lose%20weight%20(34%25)" rel="noopener ugc nofollow" target="_blank">Forbes Health/OnePoll survey</a>, thirty-four percent of respondents said that they wanted to lose weight; additionally thirty-two percent said improved diet. In 2023, Wall Street traders were a buzz around pharmaceutical manufacturers Novo Nordisk (NVO) and Eli Lily (LLY) for better-than-expected sales on prescription medications including Ozempic, Wegovy, and Mounjano. <a href="https://finance.yahoo.com/news/heres-why-merck-eli-lilly-215600306.html" rel="noopener ugc nofollow" target="_blank">This past week, bolstered by further increased weight loss drug sales, Eli Lilly stock hit an all-time — at over $745/share</a>. For the rest of 2024 and the foreseeable future, financial analysts seem to expect further widespread prescriptions of these Type 2 diabetes and anti-obesity prescriptions, which have shown the positive side-effect of appetite suppression. However, there is a more cost-effective, sustainable, and likely healthier approach — weight loss coaching. <a href="https://molly-zemek.medium.com/weight-loss-drugs-are-not-the-magic-pill-c85d7e1ebaff">Visit Now</a>